Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06422793

The Impact of Nasogastric Tube Gastric Decompression on Postoperative Nausea and Vomiting in Orthognathic Surgery

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
92 (estimated)
Sponsor
Nova Scotia Health Authority · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Accepted

Summary

This study will compare the incidence of postoperative nausea and vomiting during the first 24 hours following corrective jaw surgery (orthognathic surgery) in patients with and without nasogastric tube gastric decompression.

Detailed description

Postoperative nausea and vomiting (PONV) affects up to 60% of patients after orthognathic surgery. Multiple complex mechanisms contribute to the development of PONV, but gastric pooling of blood is speculated to be the primary stimulus in this type of surgery. Nasogastric (NG) tubes can be used for gastric decompression in the peri-operative period to evacuate gastric contents/blood, with an intent to minimize PONV. This study will directly compare the incidence of PONV in participants undergoing NG tube gastric decompression and those without NG tube gastric decompression in the first 24 hours after orthognathic surgery. Participants will be randomized into two groups including no NG tube gastric decompression or NG tube gastric decompression throughout the surgery with removal one one hour postoperatively. The presence of early and/or delayed PONV will be monitored to determine the impact of NG tube gastric decompression. This study will also evaluate the impact of other variables including type of anesthesia, length of surgery, type of surgery and patient factors on the incidence of PONV in this study population.

Conditions

Interventions

TypeNameDescription
PROCEDURENo NG tube gastric decompressionParticipants in this group will not undergo gastric decompression following orthognathic surgery at our institution.

Timeline

Start date
2024-12-04
Primary completion
2025-07-01
Completion
2025-12-01
First posted
2024-05-21
Last updated
2025-01-14

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06422793. Inclusion in this directory is not an endorsement.